A 10-day-old female neonate presents to the emergency department with severe vomiting, dehydration, and lethargy. Laboratory investigations reveal serum sodium 118 mEq/L, potassium 6.8 mEq/L, and blood glucose 42 mg/dL. Imaging shows bilateral adrenal enlargement. The structure marked **C** in the diagram (Zona Reticularis) is involved in a metabolic block that shunts precursor hormones into the androgen pathway. Which of the following is the PRIMARY DIAGNOSTIC MARKER of the enzyme deficiency affecting this zone?

Explanation

## Why "Markedly elevated 17-hydroxyprogesterone (17-OHP) on newborn screening bloodspot" is right The clinical presentation (salt-wasting crisis in a neonate with hyponatremia, hyperkalemia, and hypoglycemia) combined with bilateral adrenal enlargement is pathognomonic for congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. This enzyme deficiency blocks the conversion of 17-OH-progesterone → 11-deoxycortisol in the glucocorticoid pathway. The substrate accumulates proximal to the block and is shunted into the androgen pathway via 17,20-lyase, resulting in MARKED ELEVATION OF 17-HYDROXYPROGESTERONE — the gold-standard diagnostic marker. This is why 17-OHP measurement on newborn bloodspot screening is mandatory in all neonates and detects >90% of CAH cases before clinical crisis. The zona reticularis (structure **C**) is the site of androgen synthesis where this shunting occurs, making 17-OHP elevation the direct biochemical consequence of the block at this level. **Robbins 10e Ch 24; Harrison 21e Ch 387** ## Why each distractor is wrong - **Elevated plasma renin activity with suppressed aldosterone**: While this pattern is seen in salt-wasting CAH (due to aldosterone deficiency), it is a SECONDARY consequence of the 21-hydroxylase block affecting the mineralocorticoid pathway. Elevated renin and low aldosterone are not specific to CAH — they occur in any cause of primary adrenal insufficiency. The PRIMARY diagnostic marker specific to 21-hydroxylase deficiency is 17-OHP elevation, which reflects the substrate accumulation at the enzymatic block itself. - **Elevated ACTH with low cortisol and low aldosterone**: This pattern is correct in CAH (ACTH is elevated as a compensatory response to low cortisol), but it is NOT the PRIMARY diagnostic marker. ACTH elevation is a secondary response and is seen in all forms of primary adrenal insufficiency. The specific biochemical marker that identifies 21-hydroxylase deficiency (and distinguishes it from other causes of adrenal insufficiency) is 17-OHP, not ACTH. - **Elevated androstenedione with normal 17-hydroxyprogesterone**: This is biochemically contradictory and clinically incorrect. In 21-hydroxylase deficiency, 17-OHP is ALWAYS markedly elevated because it is the substrate that accumulates proximal to the enzymatic block. Androstenedione is elevated as a downstream product of the shunting, but 17-OHP elevation is the hallmark. A normal 17-OHP essentially excludes 21-hydroxylase deficiency CAH. **High-Yield:** 17-OHP is the GOLD-STANDARD diagnostic marker for 21-hydroxylase deficiency CAH — it is measured on newborn bloodspot screening in ALL neonates and must be checked urgently in any neonate presenting with adrenal crisis. [cite: Robbins 10e Ch 24; Harrison 21e Ch 387]